279 related articles for article (PubMed ID: 15052517)
1. Blood dyscrasias induced by psychotropic drugs.
Stübner S; Grohmann R; Engel R; Bandelow B; Ludwig WD; Wagner G; Müller-Oerlinghausen B; Möller HJ; Hippius H; Rüther E
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S70-8. PubMed ID: 15052517
[TBL] [Abstract][Full Text] [Related]
2. Severe and uncommon involuntary movement disorders due to psychotropic drugs.
Stübner S; Rustenbeck E; Grohmann R; Wagner G; Engel R; Neundörfer G; Möller HJ; Hippius H; Rüther E
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S54-64. PubMed ID: 15052515
[TBL] [Abstract][Full Text] [Related]
3. Cardiac adverse effects associated with psychotropic drugs.
Schmid C; Grohmann R; Engel RR; Rüther E; Kropp S
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S65-9. PubMed ID: 15052516
[TBL] [Abstract][Full Text] [Related]
4. Psychotropic drug use in psychiatric inpatients: recent trends and changes over time-data from the AMSP study.
Grohmann R; Engel RR; Geissler KH; Rüther E
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S27-38. PubMed ID: 15052512
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous adverse reactions to psychotropic drugs: data from a multicenter surveillance program.
Lange-Asschenfeldt C; Grohmann R; Lange-Asschenfeldt B; Engel RR; Rüther E; Cordes J
J Clin Psychiatry; 2009 Sep; 70(9):1258-65. PubMed ID: 19538904
[TBL] [Abstract][Full Text] [Related]
6. Galactorrhea due to psychotropic drugs.
Kropp S; Ziegenbein M; Grohmann R; Engel RR; Degner D
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S84-8. PubMed ID: 15052519
[TBL] [Abstract][Full Text] [Related]
7. The AMUP study for drug surveillance in psychiatry - a summary of inpatient data.
Grohmann R; Hippius H; Helmchen H; Rüther E; Schmidt LG
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S16-26. PubMed ID: 15052511
[TBL] [Abstract][Full Text] [Related]
8. Pisa syndrome (pleurothotonus): report of a multicenter drug safety surveillance project.
Stübner S; Padberg F; Grohmann R; Hampel H; Hollweg M; Hippius H; Möller HJ; Rüther E
J Clin Psychiatry; 2000 Aug; 61(8):569-74. PubMed ID: 10982199
[TBL] [Abstract][Full Text] [Related]
9. Severe adverse drug reactions in psychiatric inpatients treated with neuroleptics.
Bender S; Grohmann R; Engel RR; Degner D; Dittmann-Balcar A; Rüther E
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S46-53. PubMed ID: 15052514
[TBL] [Abstract][Full Text] [Related]
10. The AMSP drug safety program: methods and global results.
Grohmann R; Engel RR; Rüther E; Hippius H
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S4-11. PubMed ID: 15052509
[TBL] [Abstract][Full Text] [Related]
11. Haematological toxicity of drugs used in psychiatry.
Flanagan RJ; Dunk L
Hum Psychopharmacol; 2008 Jan; 23 Suppl 1():27-41. PubMed ID: 18098216
[TBL] [Abstract][Full Text] [Related]
12. Adverse psychic reactions to psychotropic drugs--a report from the AMUP study.
Grohmann R; Ströbel C; Rüther E; Dirschedl P; Helmchen H; Hippius H; Müller-Oerlinghausen B; Schmidt LG; Wolf B
Pharmacopsychiatry; 1993 May; 26(3):84-93. PubMed ID: 8415899
[TBL] [Abstract][Full Text] [Related]
13. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole).
Hedenmalm K; Spigset O
Eur J Clin Pharmacol; 2002 Jul; 58(4):265-74. PubMed ID: 12136373
[TBL] [Abstract][Full Text] [Related]
14. Blood dyscrasias in clozapine-treated patients in Italy.
Lambertenghi Deliliers G
Haematologica; 2000 Mar; 85(3):233-7. PubMed ID: 10702809
[TBL] [Abstract][Full Text] [Related]
15. [A case of neutropenia and agranulocytosis induced by clozapine. The importance of a drug surveillance program for their early detection].
Alfaro J; Berdichevsky E; Conte G; Tellez C
Rev Med Chil; 1994 Jun; 122(6):694-8. PubMed ID: 7732216
[TBL] [Abstract][Full Text] [Related]
16. Proportion of drug-related serious rare blood dyscrasias: estimates from the Berlin Case-Control Surveillance Study.
Andersohn F; Bronder E; Klimpel A; Garbe E
Am J Hematol; 2004 Nov; 77(3):316-8. PubMed ID: 15495238
[TBL] [Abstract][Full Text] [Related]
17. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
18. Clozapine-induced transient white blood count disorders.
Hummer M; Kurz M; Barnas C; Saria A; Fleischhacker WW
J Clin Psychiatry; 1994 Oct; 55(10):429-32. PubMed ID: 7961519
[TBL] [Abstract][Full Text] [Related]
19. Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugs.
Lieberman JA; Johns CA; Kane JM; Rai K; Pisciotta AV; Saltz BL; Howard A
J Clin Psychiatry; 1988 Jul; 49(7):271-7. PubMed ID: 3391979
[TBL] [Abstract][Full Text] [Related]
20. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?
Kang BJ; Cho MJ; Oh JT; Lee Y; Chae BJ; Ko J
Hum Psychopharmacol; 2006 Aug; 21(6):387-91. PubMed ID: 16933201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
